NFKB1 and inflammatory bowel disease: In this review, we describe the current understanding of the role of the HIF and NF-κB transcription factor families in response to hypoxia and inflammation and discuss their crosstalk in RA, inflammatory bowel disease and CRC, with relevance for future therapies for the management of these conditions.